DK1201639T3 - Lipoxinforbindelser og deres anvendelse til behandling af celleproliferative lidelser - Google Patents
Lipoxinforbindelser og deres anvendelse til behandling af celleproliferative lidelserInfo
- Publication number
- DK1201639T3 DK1201639T3 DK02001564T DK02001564T DK1201639T3 DK 1201639 T3 DK1201639 T3 DK 1201639T3 DK 02001564 T DK02001564 T DK 02001564T DK 02001564 T DK02001564 T DK 02001564T DK 1201639 T3 DK1201639 T3 DK 1201639T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- cell proliferative
- proliferative disorders
- lipoxin compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
- C07C69/736—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/712,610 US6048897A (en) | 1993-06-15 | 1996-09-13 | Lipoxin compounds and their use in treating cell proliferative disorders |
PCT/US1997/016342 WO1998011049A1 (en) | 1996-09-13 | 1997-09-15 | Lipoxin compounds and their use in treating cell proliferative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1201639T3 true DK1201639T3 (da) | 2008-11-24 |
Family
ID=24862848
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97941078T DK0927150T3 (da) | 1996-09-13 | 1997-09-15 | Lipoxinforbindelser og deres anvendelse til behandling af celleformeringsforstyrrelser |
DK02001564T DK1201639T3 (da) | 1996-09-13 | 1997-09-15 | Lipoxinforbindelser og deres anvendelse til behandling af celleproliferative lidelser |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97941078T DK0927150T3 (da) | 1996-09-13 | 1997-09-15 | Lipoxinforbindelser og deres anvendelse til behandling af celleformeringsforstyrrelser |
Country Status (11)
Country | Link |
---|---|
US (9) | US6048897A (da) |
EP (3) | EP2058293A1 (da) |
JP (1) | JP4060366B2 (da) |
AT (2) | ATE404522T1 (da) |
AU (1) | AU723321B2 (da) |
CA (1) | CA2265708C (da) |
DE (2) | DE69738918D1 (da) |
DK (2) | DK0927150T3 (da) |
ES (2) | ES2312499T3 (da) |
PT (2) | PT1201639E (da) |
WO (1) | WO1998011049A1 (da) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048897A (en) | 1993-06-15 | 2000-04-11 | Brigham And Women's Hospital | Lipoxin compounds and their use in treating cell proliferative disorders |
US6887901B1 (en) * | 1993-06-15 | 2005-05-03 | Brigham & Women's Hospital, Inc. | Lipoxin compounds and their use in treating cell proliferative disorders |
CZ302691B6 (cs) | 1998-07-08 | 2011-09-07 | Sanofi - Aventis Deutschland GmbH | N-Arylamidová sloucenina, zpusob její prípravy, farmaceutický prostredek tuto slouceninu obsahující, tato sloucenina pro použití jako aktivátor a pro použití k terapii nebo profylaxi |
EP1616566A1 (en) * | 1999-03-18 | 2006-01-18 | The Brigham And Women's Hospital, Inc. | Lipoxin compounds for treating TNF-alpha initiated inflammation |
AU2004235617B2 (en) * | 1999-03-18 | 2008-06-05 | The Brigham And Women's Hospital, Inc. | Lipoxin compounds and their use |
AU775140B2 (en) | 1999-03-18 | 2004-07-22 | Brigham And Women's Hospital | Use of lipoxin compounds for inhibiting of TNF-(alfa) initiated neutrophil response |
EP1586550A1 (en) * | 1999-03-18 | 2005-10-19 | The Brigham And Women's Hospital, Inc. | Lipoxin compounds and their use |
DK1163204T3 (da) | 1999-03-18 | 2005-12-19 | Brigham & Womens Hospital | Lipoxinforbindelser og deres anvendelse |
DK1237549T3 (da) | 1999-11-09 | 2004-06-07 | Alcon Inc | Lipoxin A4 og dets analoger til behandling af törre öjne |
AU3846801A (en) | 2000-02-16 | 2001-08-27 | Brigham & Womens Hospital | Aspirin-triggered lipid mediators |
EP1268393A2 (en) | 2000-03-20 | 2003-01-02 | Trustees Of Boston University | Lipoxin analogs and methods for the treatment of periodontal disease |
ATE412448T1 (de) * | 2001-03-02 | 2008-11-15 | Brigham & Womens Hospital | Lipoxin analoge als neue inhibitoren der angiogenese |
ATE468157T1 (de) * | 2001-03-02 | 2010-06-15 | Brigham & Womens Hospital | Lipoxinanaloge als neuartige restenose-hemmer |
US8722654B2 (en) | 2001-03-02 | 2014-05-13 | The Brigham And Women's Hospital, Inc. | Lipoxin analogs as novel inhibitors of angiogenesis |
GB0119583D0 (en) * | 2001-08-10 | 2001-10-03 | Unilever Plc | Cosmetic composition and method of treating skin |
US6831186B2 (en) | 2001-11-06 | 2004-12-14 | Schering Aktiengesellschft | Lipoxin A4 analogs |
EP1911448B1 (en) * | 2001-11-06 | 2013-01-02 | The Brigham and Women's Hospital, Inc. | Lipoxins and Aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
WO2003039533A1 (en) * | 2001-11-06 | 2003-05-15 | The Brigham And Women's Hospital, Inc. | Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
WO2003053423A2 (en) * | 2001-12-18 | 2003-07-03 | The Brigham And Women's Hospital | Inhibition or prevention of infection by bacteria with epa, dha or analogs |
EP1458373A1 (en) * | 2001-12-18 | 2004-09-22 | The Brigham and Women's Hospital | Use of lipoxin analogs to promote cell defense against gram-negative infections |
EP1941875B1 (en) * | 2001-12-18 | 2012-09-12 | The Brigham and Women's Hospital | Use of lipoxin analogs to promote cell defense against gram-negative infections |
US8481772B2 (en) | 2002-04-01 | 2013-07-09 | University Of Southern California | Trihydroxy polyunsaturated eicosanoid derivatives |
US7902257B2 (en) | 2002-04-01 | 2011-03-08 | University Of Southern California | Trihydroxy polyunsaturated eicosanoid |
US7582785B2 (en) * | 2002-04-01 | 2009-09-01 | University Of Southern California | Trihydroxy polyunsaturated eicosanoid derivatives |
US7759395B2 (en) * | 2002-08-12 | 2010-07-20 | The Brigham And Women's Hospital, Inc. | Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma |
ES2700133T3 (es) | 2002-08-12 | 2019-02-14 | Brigham & Womens Hospital | Resolvinas: modelos biológicos para intervenciones terapéuticas |
WO2004078143A2 (en) * | 2003-03-05 | 2004-09-16 | The Brigham And Women's Hospital Inc. | Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs |
GB0313259D0 (en) * | 2003-06-09 | 2003-07-16 | Consejo Superior Investigacion | Magnetic nanoparticles |
US20050250694A1 (en) * | 2003-10-10 | 2005-11-10 | Ma Jian-Xing | Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same |
US20050130897A1 (en) * | 2003-12-11 | 2005-06-16 | Ma Jian-Xing | Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same |
WO2005105025A1 (en) * | 2004-04-14 | 2005-11-10 | Boston University | Methods and compositions for preventing or treating periodontal diseases |
US7879905B2 (en) * | 2004-11-09 | 2011-02-01 | Alcon, Inc. | 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
US20060293288A1 (en) * | 2005-01-07 | 2006-12-28 | Serhan Charles N | Use of resolvins to treat gastrointestinal diseases |
US8245230B2 (en) * | 2005-03-14 | 2012-08-14 | Qnx Software Systems Limited | Adaptive partitioning scheduler for multiprocessing system |
WO2007041440A2 (en) * | 2005-10-03 | 2007-04-12 | The Brigham And Women's Hospital, Inc. | Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers |
US20100029504A1 (en) | 2007-01-16 | 2010-02-04 | Phigenix, Inc. | Detecting pax2 for the diagnosis of breast cancer |
US8636986B2 (en) * | 2005-11-18 | 2014-01-28 | The Forsyth Institute | Treatment and prevention of bone loss using resolvins |
US20070254897A1 (en) * | 2006-04-28 | 2007-11-01 | Resolvyx Pharmaceuticals, Inc. | Compositions and methods for the treatment of cardiovascular disease |
PE20120395A1 (es) | 2006-12-04 | 2012-05-23 | Bayer Ip Gmbh | Sal de potasio cristalina de analogos de lipoxina a4 |
US20080287341A1 (en) * | 2007-05-18 | 2008-11-20 | Danyang Chen | Treatment of vascular abnormalities using nanoparticles |
JP2009026126A (ja) * | 2007-07-20 | 2009-02-05 | Nec Electronics Corp | 半導体装置 |
CN101843622B (zh) * | 2010-04-27 | 2011-09-14 | 黄波 | 脂氧素在制备女性避孕药物中的应用 |
US9439966B2 (en) | 2011-10-12 | 2016-09-13 | Case Western Reserve University | Multi-component nanochains |
WO2014072537A1 (de) | 2012-11-12 | 2014-05-15 | Biocrates Life Sciences Ag | Verwendung von qualitätsindikatoren zum nachweis von auftauprozessen in gefrorenen gewebeproben |
CN105439813B (zh) * | 2014-08-08 | 2017-10-27 | 广州丹康医药生物有限公司 | 化合物的合成方法 |
CA3026264A1 (en) | 2016-06-03 | 2017-12-07 | Thetis Pharmaceuticals Llc | Compositions and methods relating to salts of specialized pro-resolving mediators |
US11592453B2 (en) | 2016-11-22 | 2023-02-28 | The Brigham And Women's Hospital, Inc. | Personalized metabolomic profiling of specialized pro-resolving mediators |
US11439615B2 (en) | 2017-03-09 | 2022-09-13 | University Health Network | Lipoxin and lipoxin analogue mediated neuroprotection and treatments |
WO2023168245A2 (en) | 2022-03-03 | 2023-09-07 | Thetis Pharmaceuticals Llc | Cyclodextrin complexes of specialized proresolving mediators |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4560514A (en) * | 1984-05-04 | 1985-12-24 | Bengt Samuelsson | Inflammatory lipoxin A and anti-anflammatory lipoxin B compounds |
US4576758A (en) * | 1984-06-01 | 1986-03-18 | The Upjohn Company | Anti-inflammatory lipoxin B analogs |
US4780281A (en) | 1985-06-14 | 1988-10-25 | Wayne State University | Method for assay of peroxidase enzyme or reducing substrate activity |
JPS62198677A (ja) | 1986-02-26 | 1987-09-02 | Nissan Chem Ind Ltd | テトラオ−ル誘導体 |
JPH0739368B2 (ja) | 1986-10-01 | 1995-05-01 | 旭硝子株式会社 | 20,20,20−トリフルオロアラキドン酸誘導体およびその製造法 |
CA1329809C (en) * | 1987-07-08 | 1994-05-24 | Nissan Chemical Industries, Ltd. | Optically active allyl alcohol and process for producing leucotriene b_ using thereof |
JPH01228994A (ja) | 1988-03-10 | 1989-09-12 | Fumie Satou | γ−シリルアリルアルコール及びその製造法 |
US5079261A (en) * | 1989-04-28 | 1992-01-07 | Brigham And Women's Hospital | Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
JP2834512B2 (ja) | 1990-01-30 | 1998-12-09 | 帝人株式会社 | リポキシン誘導体を有効成分とする疾患治療剤 |
US5322699A (en) | 1991-02-04 | 1994-06-21 | The Rockefeller University | Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1) |
US5650435A (en) | 1991-04-01 | 1997-07-22 | Madara; James L. | Modulation of inflammation related to columnar epithelia |
JP3227922B2 (ja) | 1993-01-20 | 2001-11-12 | 富士電機株式会社 | 自動販売機 |
US6048897A (en) * | 1993-06-15 | 2000-04-11 | Brigham And Women's Hospital | Lipoxin compounds and their use in treating cell proliferative disorders |
ATE405539T1 (de) * | 1993-06-15 | 2008-09-15 | Brigham & Womens Hospital | Lipoxinverbindungen mit verlängerter halbwertszeit |
US5441951A (en) | 1994-06-15 | 1995-08-15 | Brigham & Women's Hospital | Lipoxin compounds |
WO1995001179A1 (en) | 1993-06-29 | 1995-01-12 | Brigham & Women's Hospital | Modulation of inflammation related to columnar epithelia |
US5998487A (en) | 1998-04-08 | 1999-12-07 | Colgate-Palmolive Company | Anti-inflammatory and antibacterial benzyl phenol agents and their use in oral compositions |
US6486203B1 (en) | 1998-09-08 | 2002-11-26 | Cornell Research Foundation, Inc. | Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors |
EP1268393A2 (en) | 2000-03-20 | 2003-01-02 | Trustees Of Boston University | Lipoxin analogs and methods for the treatment of periodontal disease |
-
1996
- 1996-09-13 US US08/712,610 patent/US6048897A/en not_active Expired - Lifetime
-
1997
- 1997-09-15 PT PT02001564T patent/PT1201639E/pt unknown
- 1997-09-15 DK DK97941078T patent/DK0927150T3/da active
- 1997-09-15 EP EP08014341A patent/EP2058293A1/en not_active Withdrawn
- 1997-09-15 EP EP02001564A patent/EP1201639B1/en not_active Expired - Lifetime
- 1997-09-15 EP EP97941078A patent/EP0927150B1/en not_active Expired - Lifetime
- 1997-09-15 ES ES02001564T patent/ES2312499T3/es not_active Expired - Lifetime
- 1997-09-15 PT PT97941078T patent/PT927150E/pt unknown
- 1997-09-15 ES ES97941078T patent/ES2175460T3/es not_active Expired - Lifetime
- 1997-09-15 CA CA002265708A patent/CA2265708C/en not_active Expired - Fee Related
- 1997-09-15 AT AT02001564T patent/ATE404522T1/de active
- 1997-09-15 DK DK02001564T patent/DK1201639T3/da active
- 1997-09-15 DE DE69738918T patent/DE69738918D1/de not_active Expired - Lifetime
- 1997-09-15 AT AT97941078T patent/ATE215924T1/de active
- 1997-09-15 JP JP51396298A patent/JP4060366B2/ja not_active Expired - Fee Related
- 1997-09-15 DE DE69711894T patent/DE69711894T2/de not_active Expired - Lifetime
- 1997-09-15 WO PCT/US1997/016342 patent/WO1998011049A1/en active IP Right Grant
- 1997-09-15 AU AU42710/97A patent/AU723321B2/en not_active Ceased
-
1999
- 1999-05-11 US US09/309,423 patent/US6316648B1/en not_active Expired - Fee Related
-
2001
- 2001-03-09 US US09/803,347 patent/US6750360B2/en not_active Expired - Fee Related
- 2001-03-09 US US09/803,402 patent/US20020091279A1/en not_active Abandoned
- 2001-03-09 US US09/803,549 patent/US6653493B2/en not_active Expired - Fee Related
- 2001-03-09 US US09/803,552 patent/US20010031882A1/en not_active Abandoned
- 2001-10-01 US US09/968,445 patent/US6569075B2/en not_active Expired - Fee Related
-
2002
- 2002-06-19 US US10/175,268 patent/US6620919B2/en not_active Expired - Fee Related
- 2002-12-02 US US10/307,811 patent/US6635776B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1201639T3 (da) | Lipoxinforbindelser og deres anvendelse til behandling af celleproliferative lidelser | |
ATE286392T1 (de) | Photodynamische behandlung von synovium | |
NO20005884D0 (no) | Kombinasjonsterapi for behandling av bipolare forstyrrelser | |
DK0933995T3 (da) | Fremgangsmåde til behandling af endotelskader | |
DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
DE69708121D1 (de) | Halogenid-enthaltende insulinzubereitungen | |
DK0703897T3 (da) | Lipoxinforbindelser med forlænget halveringstid | |
DE69133022D1 (de) | Viral verursachte Zerstörung von Neoplastzellen | |
DK1237549T3 (da) | Lipoxin A4 og dets analoger til behandling af törre öjne | |
DK1702618T3 (da) | Brug af ET743 i kombinationsterapi med dexamethason til behandling af cancer | |
DE69814394D1 (de) | Verwendung von levobupivacain | |
ATE368455T1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
ATE317849T1 (de) | 5-hydroxysapogenin derivate mit aktivität gegen demenz | |
IS5366A (is) | Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi | |
DK0971710T3 (da) | Anvendelse af chelerythrin og stråling til tumorterapi | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
DK0799618T3 (da) | Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer | |
MXPA01007952A (es) | Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas. | |
JO2199B1 (en) | Replaced pyrrols | |
IT1320192B1 (it) | Composizione terapeutica per la cura della psoriasi. | |
DE59101818D1 (de) | Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung. | |
DE69821227D1 (de) | Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen | |
DK0994703T3 (da) | Sammensætning omfattende ketanserin og L-carnitin til behandlingen af CRPS | |
DK1463541T3 (da) | Biomaterialer baseret på hyaluronsyrebenzylester til anti-angiogen terapi i behandling af tumorer | |
UA8280A (uk) | Спосіб лікування псоріазу |